Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-04-26

FDA Approved: GEFITINIB — Original Application (Teva Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Teva Pharmaceuticals' generic Gefitinib under an Original Application (ANDA 208913). The approval enables Teva to market Gefitinib for the treatmen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gefitinib (Gefitinib)

Snippet

ORIG AP for GEFITINIB (GEFITINIB)